The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
The 6-Hydroxydopamine model of parkinson’s disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
Applications of the Morris water maze in the study of learning and memory
D’Hooge, R., & De Deyn, P. P. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00067-4 · Cited by 2,040
Ungerstedt, U., & Arbuthnott, G. W. (1970) · Brain Research · doi:10.1016/0006-8993(70)90187-3 · Cited by 1,978
Handbook of Experimental Pharmacology.
Meakin, J. W. (1971) · Archives of Internal Medicine · doi:10.1001/archinte.1971.00310230151026 · Cited by 1,959
CREB: a Ca 2+ -Regulated Transcription Factor Phosphorylated by Calmodulin-Dependent Kinases
Sheng, M., Thompson, M. A., & Greenberg, M. E. (1991) · Science · doi:10.1126/science.1646483 · Cited by 1,488
Functional Repression of cAMP Response Element in 6-Hydroxydopamine-treated Neuronal Cells
Chalovich, E. M., Zhu, J.-H., Caltagarone, J., Bowser, R., & Chu, C. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602632200 · Cited by 1,371
Schallert, T., Fleming, S. M., Leasure, J. L., Tillerson, J. L., & Bland, S. T. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00005-8 · Cited by 1,354
Blum, D., Torch, S., Lambeng, N., Nissou, M.-F., Benabid, A.-L., Sadoul, R., & Verna, J.-M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00003-x · Cited by 1,246
Freund, T. F., Powell, J. F., & Smith, A. D. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90294-x · Cited by 865
Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia
Ferré, S., Fuxe, K., B. Fredholm, B., Morelli, M., & Popoli, P. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01096-5 · Cited by 824
Self-citationModeling Parkinson's Disease in Rats: An Evaluation of 6-OHDA Lesions of the Nigrostriatal Pathway
Deumens, R., Blokland, A., & Prickaerts, J. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7891 · Cited by 758
Day, M., Wang, Z., Ding, J., An, X., Ingham, C. A., Shering, A. F., Wokosin, D., Ilijic, E., Sun, Z., Sampson, A. R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1632 · Cited by 745 · cited 1×
“…several studies have reported a decrease in glutamatergic synapses in the ipsilateral striatum of rats unilaterally injected with 6-OHDA, particularly of those located in striatopallidal neurons, whereas synapses on striatonigral neurons seem to be spared (Ingham et al., 1998; Day et al., 2006).”
Lundblad, M., Andersson, M., Winkler, C., Kirik, D., Wierup, N., & Cenci, M. A. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01843.x · Cited by 664
Regulation of NMDA receptors by tyrosine kinases and phosphatases
Wang, Y. T., & Salter, M. W. (1994) · Nature · doi:10.1038/369233a0 · Cited by 662
Cenci, M. A., Lee, C. S., & Björklund, A. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00285.x · Cited by 641
Olsson, M., Nikkhah, G., Bentlage, C., & Bjorklund, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03863.1995 · Cited by 625
The “staircase test”: a measure of independent forelimb reaching and grasping abilities in rats
Montoya, C. P., Campbell-Hope, L. J., Pemberton, K. D., & Dunnett, S. B. (1991) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(91)90048-5 · Cited by 609
Dash, P. K., Karl, K. A., Colicos, M. A., Prywes, R., & Kandel, E. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.5061 · Cited by 551
Schiffmann, S. N., Jacobs, O., & Vanderhaeghen, J. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08257.x · Cited by 530
Invited Review Free radicals and the pathobiology of brain dopamine systems
Cadet, J. L., & Brannock, C. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(97)00031-4 · Cited by 499
Zbarsky, V., Datla, K. P., Parkar, S., Rai, D. K., Aruoma, O. I., & Dexter, D. T. (2005) · Free Radical Research · doi:10.1080/10715760500233113 · Cited by 462
Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons
Lotharius, J., Dugan, L. L., & O’Malley, K. L. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01284.1999 · Cited by 403
Hudson, J. L., van Horne, C. G., Strömberg, I., Brock, S., Clayton, J., Masserano, J., Hoffer, B. J., & Gerhardt, G. A. (1993) · Brain Research · doi:10.1016/0006-8993(93)90576-9 · Cited by 377
Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice
Iancu, R., Mohapel, P., Brundin, P., & Paul, G. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.02.023 · Cited by 376
Gerfen, C. R., Miyachi, S., Paletzki, R., & Brown, P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-05042.2002 · Cited by 373
Dunah, A. W., & Standaert, D. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05546.2001 · Cited by 373
Cole, R. L., Konradi, C., Douglass, J., & Hyman, S. E. (1995) · Neuron · doi:10.1016/0896-6273(95)90225-2 · Cited by 365
Lundblad, M., Picconi, B., Lindgren, H., & Cenci, M. A. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.01.007 · Cited by 330
Sgambato, V., Pagès, C., Rogard, M., Besson, M.-J., & Caboche, J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-21-08814.1998 · Cited by 328
Chemical Neurotoxins as Denervation Tools in Neurobiology
Jonsson, G. (1980) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.03.030180.001125 · Cited by 323
Electrophysiology of dopamine-denervated striatal neurons
Brink, E. E., & Mackel, R. G. (1993) · Brain · doi:10.1093/brain/116.2.433 · Cited by 320
Soto‐Otero, R., Méndez‐Álvarez, E., Hermida‐Ameijeiras, Á., Muñoz‐Patiño, A. M., & Labandeira‐Garcia, J. L. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741605.x · Cited by 314
Breese, G. R., Baumeister, A. A., McCown, T. J., Emerick, S. G., Frye, G. D., Crotty, K., & Mueller, R. A. (1984) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21630-5 · Cited by 294
Ingham, C. A., Hood, S. H., Taggart, P., & Arbuthnott, G. W. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04732.1998 · Cited by 291
Crofts, H. S. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.11.1015 · Cited by 284
Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine
Glinka, Y. Y., & Youdim, M. B. H. (1995) · European Journal of Pharmacology: Environmental Toxicology and Pharmacology · doi:10.1016/0926-6917(95)90040-3 · Cited by 283
Dunah, A. W., Wang, Y., Yasuda, R. P., Kameyama, K., Huganir, R. L., Wolfe, B. B., & Standaert, D. G. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23206-5 · Cited by 263
Choi, W.-S., Yoon, S.-Y., Oh, T. H., Choi, E.-J., O'Malley, K. L., & Oh, Y. J. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990701)57:1<86::aid-jnr9>3.0.co;2-e · Cited by 261
Höglinger, G. U., Carrard, G., Michel, P. P., Medja, F., Lombès, A., Ruberg, M., Friguet, B., & Hirsch, E. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01952.x · Cited by 253
Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism
Chase, T. N., & Oh, J. D. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00018-5 · Cited by 251
Chang, J.-W., Wachtel, S. R., Young, D., & Kang, U.-J. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00217-6 · Cited by 248
Linert, W., Herlinger, E., Jameson, R. F., Kienzl, E., Jellinger, K., & Youdim, M. B. H. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(96)00020-8 · Cited by 238
Papa, S. M., Engber, T. M., Kask, A. M., & Chase, T. N. (1994) · Brain Research · doi:10.1016/0006-8993(94)90796-x · Cited by 235
YOUDIM, M. B. H., STEPHENSON, G., & SHACHAR, D. B. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.025 · Cited by 233 · cited 1×
“The facilitatory influence of iron on 6- OHDA effects (Double et al., 1998; Youdim et al., 2004) represents an additional shared feature, since iron has been suggested to play an important role in the onset of human neurodegenerative diseases, including PD (Kienzl et al., 1999).”
Hallett, P. J., Spoelgen, R., Hyman, B. T., Standaert, D. G., & Dunah, A. W. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0792-06.2006 · Cited by 225
Andrew, R., Watson, D. G., Best, S. A., Midgley, J. M., Wenlong, H., & Petty, R. K. H. (1993) · Neurochemical Research · doi:10.1007/bf00978370 · Cited by 225
Oxy-radical toxicity in catecholamine neurons.
Cohen, G. (1984) · PubMed · Cited by 222
Anichtchik, O. V., Kaslin, J., Peitsaro, N., Scheinin, M., & Panula, P. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02190.x · Cited by 221
Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion
Meshul, C. K., Emre, N., Nakamura, C. M., Allen, C., Donohue, M. K., & Buckman, J. F. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00189-4 · Cited by 209
BREESE, G. R., & TRAYLOR, T. D. (1972) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1972.tb07257.x · Cited by 207
Somogyi, P., Bolam, J. P., Totterdell, S., & Smith, A. D. (1981) · Brain Research · doi:10.1016/0006-8993(81)90002-0 · Cited by 207
Henry, B., Crossman, A. R., & Brotchie, J. M. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6819 · Cited by 187
Blandini, F., Levandis, G., Bazzini, E., Nappi, G., & Armentero, M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05285.x · Cited by 185
Nature of Inhibition of Mitochondrial Respiratory Complex I by 6‐Hydroxydopamine
Glinka, Y., Tipton, K. F., & Youdim, M. B. H. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66052004.x · Cited by 176
Spatial memory impairment induced by lesion of the mesohippocampal dopaminergic system in the rat
Gasbarri, A., Sulli, A., Innocenzi, R., Pacitti, C., & Brioni, J. D. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00202-3 · Cited by 175
Ventrolateral striatal dopamine depletions impair feeding and food handling in rats
Salamone, J. D., Mahan, K., & Rogers, S. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90174-r · Cited by 173
Luthman, J., Fredriksson, A., Sundström, E., JONSSON, G., & Archer, T. (1989) · Behavioural Brain Research · doi:10.1016/s0166-4328(89)80121-4 · Cited by 169
Cadet, J. L., Katz, M., Jackson-Lewis, V., & Fahn, S. (1989) · Brain Research · doi:10.1016/0006-8993(89)91530-8 · Cited by 163
Tremulous jaw movements in rats:a model of parkinsonian tremor
Salamone, J. D., Mayorga, A. J., Trevitt, J. T., Cousins, M. S., Conlan, A., & Nawab, A. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00053-7 · Cited by 161
Picconi, B., Gardoni, F., Centonze, D., Mauceri, D., Cenci, M. A., Bernardi, G., Calabresi, P., & Luca, M. D. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1224-04.2004 · Cited by 160
Oh, J. D., Russell, D., Vaughan, C. L., & Chase, T. N. (1998) · Brain Research · doi:10.1016/s0006-8993(98)01049-x · Cited by 153
In Vitro Studies of Ferritin Iron Release and Neurotoxicity
Double, K. L., Maywald, M., Schmittel, M., Riederer, P. F., & Gerlach, M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70062492.x · Cited by 152
Early cognitive changes and nondementing behavioral abnormalities in Parkinson's disease.
Levin, B. E., & Katzen, H. (1995) · PubMed · Cited by 149
Andersson, M., Konradi, C. L., & Cenci, M. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09930.2001 · Cited by 145
Ingham, C. A., Hood, S. H., van Maldegem, B., Weenink, A., & Arbuthnott, G. W. (1993) · Experimental Brain Research · doi:10.1007/bf00227776 · Cited by 144
Woodlee, M. T., ASSEOGARCIA, A., ZHAO, X., LIU, S., Jones, T. A., & Schallert, T. J. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.09.005 · Cited by 140
Persistent Behavioral Sensitization to Chronic l-DOPA Requires A2AAdenosine Receptors
Fredduzzi, S., Moratalla, R., Monopoli, A., Cuéllar, B., Xu, K., Ongini, E., Impagnatiello, F., Schwarzschild, M. A., & Chen, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-01054.2002 · Cited by 128
Marshall, J. F., Navarrete, R. J., & Joyce, J. N. (1989) · Brain Research · doi:10.1016/0006-8993(89)91160-8 · Cited by 123
Jellinger, K. A., Linert, L., Kienzl, E., Herlinger, E., & Youdim, M. B. H. (1995) · PubMed · Cited by 121
Oh, J. D., Vaughan, C. L., & Chase, T. N. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01121-x · Cited by 118
Cohen, G., Heikkila, R. E., Allis, B., Cabbat, F. S., Dembiec, D., MacNamee, D., Mytilineou, C., & Winston, B. (1976) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30688-9 · Cited by 113
Phosphorylation-dependent Regulation ofN-Methyl-d-aspartate Receptors by Calmodulin
Hisatsune, C., Umemori, H., Inoue, T., Michikawa, T., Kohda, K., Mikoshiba, K., & Yamamoto, T. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20805 · Cited by 111
Gerfen, C. R. (2003) · The Neuroscientist · doi:10.1177/1073858403255839 · Cited by 108
Lindner, M. D., Cain, C. K., Plone, M. A., Frydel, B. R., Blaney, T. J., Emerich, D. F., & Hoane, M. R. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(98)00160-0 · Cited by 107
Gardoni, F., Bellone, C., Cattabeni, F., & Luca, M. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009922200 · Cited by 106
Amalric, M., Moukhles, H., Nieoullon, A., & Daszuta, A. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01085.x · Cited by 106
Manganese Superoxide Dismutase Protects against 6-Hydroxydopamine Injury in Mouse Brains
Callio, J., Oury, T. D., & Chu, C. T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413224200 · Cited by 104
Breese, G. R., Knapp, D. J., Criswell, H. E., Moy, S. S., Papadeas, S. T., & Blake, B. L. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.08.004 · Cited by 104
Jiang, H., Jackson-Lewis, V. R., Muthane, U. B., Dollison, A. M., Ferreira, M., Espinosa, A., Parsons, B., & Przedborski, S. (1993) · Brain Research · doi:10.1016/0006-8993(93)90925-d · Cited by 99
Generation of the Neurotoxin 6-Hydroxydopamine by Peroxidase/H2O2 Oxidation of Dopamine
Napolitano, A., Crescenzi, O., Pezzella, A., & Prota, G. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00006a010 · Cited by 95
Storch, A., Kaftan, A., Burkhardt, K., & Schwarz, J. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050023 · Cited by 95
Tyrosine phosphorylation of NMDA receptor in rat striatum: effects of 6-OH-dopamine lesions
Menegoz, M., Lau, L., Hervé, D., et al. (1995) · Neuroreport · doi:10.1097/00001756-199512290-00030 · Cited by 93
Attenuation of 6‐OHDA‐induced neurotoxicity in glutathione peroxidase transgenic mice
Bensadoun, J., Mirochnitchenko, O. V., Inouye, M., Aebischer, P., & Zurn, A. D. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00345.x · Cited by 92
Morelli, M., & Chiara, G. D. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90415-8 · Cited by 91
Self-citationAsanuma, M., Hirata, H., & Cadet, J. L. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00665-9 · Cited by 88
Whishaw, I. Q., Woodward, N. C., Miklyaeva, E. I., & Pellis, S. M. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00057-0 · Cited by 87
Pileblad, E., Magnusson, T., & Fornstedt, B. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb02550.x · Cited by 87
Palumbo, A., Napolitano, A., Barone, P., & d’Ischia, M. (1999) · Chemical Research in Toxicology · doi:10.1021/tx990121g · Cited by 86
Barnéoud, P., Descombris, E., Aubin, N., & Abrous, D. N. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00896.x · Cited by 85
Proposed animal model of attention deficit hyperactivity disorder
Kostrzewa, R. M., Brus, R., Kalbfleisch, J. H., Perry, K. W., & Fuller, R. W. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90013-2 · Cited by 79
Ridet, J., Bensadoun, J., Déglon, N., Aebischer, P., & Zurn, A. D. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.06.003 · Cited by 78
Pinna, A., Corsi, C., Carta, A. R., Valentini, V., Pedata, F., & Morelli, M. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01818-6 · Cited by 78
Self-citationFinn, M., Jassen, A., Baskin, P. P., et al. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00385-1 · Cited by 64
Regional effects of 6-hydroxydopamine (6-OHDA) on free radical scavengers in rat brain
Perumal, A. S., Tordzro, W. K., Katz, M., Jackson-Lewis, V. R., Cooper, T. B., Fahn, S., & Cadet, J. L. (1989) · Brain Research · doi:10.1016/0006-8993(89)91611-9 · Cited by 63
Iron as catalyst for oxidative stress in the pathogenesis of Parkinson's disease?
Kienzl, E., Jellinger, K. A., Stachelberger, H., & Linert, W. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00458-0 · Cited by 62
Impaired problem solving in Parkinson's disease: Impact of a set-shifting deficit
Cronin‐Golomb, A., Corkin, S., & Growdon, J. H. (1994) · Neuropsychologia · doi:10.1016/0028-3932(94)90146-5 · Cited by 60
Oh, J. D., & Chase, T. N. (2002) · Amino Acids · doi:10.1007/s00726-001-0118-2 · Cited by 58
Eslamboli, A. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00139-0 · Cited by 51
Cousins, M. S., & Salamone, J. D. (1996) · Brain Research · doi:10.1016/0006-8993(96)00519-7 · Cited by 47
Morelli, M., & Chiara, G. D. (1990) · Psychopharmacology · doi:10.1007/bf02244143 · Cited by 46
Self-citationPapadeas, S. T., Blake, B. L., Knapp, D. J., & Breese, G. R. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0528-04.2004 · Cited by 45
Oueslati, A., Breysse, N., Amalric, M., Goff, L. K., & Salin, P. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04498.x · Cited by 45
Marı́n, C., Aguilar, E., Bonastre, M., et al. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.10.008 · Cited by 44
Mitchell, I., & Carroll, C. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00036-x · Cited by 42
Functional interaction between mGlu 5 and NMDA receptors in a rat model of Parkinson?s disease
Turle-Lorenzo, N., Breysse, N., Baunez, C., & Amalric, M. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2202-x · Cited by 41
Carta, A. R., Fenu, S., Pala, P., Tronci, E., & Morelli, M. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02983.x · Cited by 40
Self-citation6‐hydroxydopamine lesions in anuran amphibians: A new model system for Parkinson's disease?
Endepols, H., Schul, J., Gerhardt, H. C., & Walkowiak, W. (2004) · Journal of Neurobiology · doi:10.1002/neu.20047 · Cited by 38
Mandel, R. J., & Randall, P. K. (1985) · Brain Research · doi:10.1016/0006-8993(85)90698-5 · Cited by 36
Betarbet, R. S., Poisik, O. V., Sherer, T., & Greenamyre, J. T. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.12.012 · Cited by 35
Vallone, D., Pellecchia, M. T., Morelli, M., Verde, P., DiChiara, G., & Barone, P. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00253-2 · Cited by 35
Self-citationLuthman, J., Bassen, M., Fredriksson, A., & Archer, T. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)80991-6 · Cited by 34
Kelsey, J. E., Mague, S. D., Pijanowski, R., Harris, R., Kleckner, N. W., & Matthews, R. T. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1799-5 · Cited by 32
Morelli, M., Pontieri, F. E., Linfante, I., Orzi, F., & Chiara, G. D. (1993) · Synapse · doi:10.1002/syn.890130309 · Cited by 31
Self-citationManganese catalyzed auto-oxidation of dopamine to 6-Hydroxydopamine in vitro
Garner, C. D., & Nachtman, J. P. (1989) · Chemico-Biological Interactions · doi:10.1016/0009-2797(89)90120-8 · Cited by 30
Dopamine receptor supersensitivity: An outcome and index of neurotoxicity
Kostrzewa, R. M., Kostrzewa, J. P., & Brus, R. (2003) · Neurotoxicity Research · doi:10.1007/bf03033376 · Cited by 29
Ganguly, A., & Keefe, K. A. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00005-7 · Cited by 28
Oh, J. D., Chartisathian, K., Ahmed, S. M., & Chase, T. N. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10629 · Cited by 25
Modulation of 6-hydroxydopamine oxidation by various proteins
Padiglia, A., Medda, R., Lorrai, A., Biggio, G., Sanna, E., & Floris, G. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00716-2 · Cited by 24
Neglect of memory after dopaminergic lesions in monkeys
Ridley, R. M., Cummings, R. M., Leow-Dyke, A., & Baker, H. F. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.08.007 · Cited by 24
Pinna, A., Morelli, M., Drukarch, B., et al. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01067-4 · Cited by 21
Self-citationSchwarzkopf, S. B., Ison, J. R., Bruno, J. P., & Mitra, T. (1996) · Psychopharmacology · doi:10.1007/bf02246580 · Cited by 20
Consolo, S., Morelli, M., Rimoldi, M., Giorgi, S., & Chiara, G. D. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00390-x · Cited by 18
Self-citationDecrease in adrenaline content of various organs of the rat after 6-hydroxydopamine
Ayako, S. U. D. O. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90524-2 · Cited by 16
Takasuna, M., & Iwasaki, T. (1996) · Behavioural Brain Research · doi:10.1016/0166-4328(95)00148-4 · Cited by 16
Arts, M. P. M., & Cools, A. R. (1998) · Behavioral Neuroscience · doi:10.1037/0735-7044.112.1.102 · Cited by 12
An avian model for the reversal of 6-hydroxydopamine induced rotating behaviour by neural grafting
Yanai, J., Silverman, W. F., & Shamir, D. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11361-y · Cited by 10
Liao, R., Fowler, S. C., & Kallman, M. J. (1997) · PubMed · Cited by 9
Heim, C. C., Sova, L., Kurz, T., Kolasiewicz, W., Schwegler, H., & Sontag, K. ‐. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200058 · Cited by 8
Pilowsky, P. M., Morris, M. J., Kapoor, V., West, M., & Chalmers, J. P. (1986) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(86)90086-x · Cited by 8
Sunn, N., Harris, P. J. F., & Bell, C. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb12985.x · Cited by 7
Depletion of central catecholamines reduces pressor responses to arginine vasopressin
Franklin, L., Bauce, L., & Pittman, Q. J. (1988) · Brain Research · doi:10.1016/0006-8993(88)91350-9 · Cited by 5
Cited by
The SH-SY5Y cell line in Parkinson’s disease research: a systematic review
Xicoy, H., Wieringa, B., & Martens, G. J. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0149-0 · Cited by 1,036
Gillies, G. E., & McArthur, S. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002071 · Cited by 733
Pathophysiology of Parkinsonism
Galvan, A., & Wichmann, T. (2008) · Clinical Neurophysiology · doi:10.1016/j.clinph.2008.03.017 · Cited by 549
Sex differences in Parkinson’s disease
Gillies, G. E., Pienaar, I. S., Vohra, S., & Qamhawi, Z. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.02.002 · Cited by 489
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P.-O., Feyder, M., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.002 · Cited by 475
Self-citation
Metadata
- Authors
- Simola, N., Morelli, M., & Carta, A. R.
- Venue
- Neurotoxicity Research
- Published
- 2007-09
- Volume
- 11
- Issue
- 3-4
- Pages
- 151-167
- ISSN
- 1029-8428 (ISSN-L)
- 1476-3524
- OpenAlex
- W2139086927
- Cited by
- 514
- References
- 132
- FWCI
- 7.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.